| Product Code: ETC8877873 | Publication Date: Sep 2024 | Updated Date: Nov 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sumit Sagar | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
Portugal`s import of antivirals in 2024 was primarily sourced from Germany, Spain, Belgium, Metropolitan France, and the Netherlands. The market shows low concentration with the Herfindahl-Hirschman Index (HHI) remaining stable. The compound annual growth rate (CAGR) from 2020 to 2024 stood at 2.5%, indicating a steady increase in imports. Additionally, the growth rate from 2023 to 2024 was recorded at 2.21%, showcasing a positive trend in the market. The consistent growth and diverse sourcing point towards a healthy and competitive landscape for antiviral imports in Portugal.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Portugal Antivirals Market Overview |
3.1 Portugal Country Macro Economic Indicators |
3.2 Portugal Antivirals Market Revenues & Volume, 2021 & 2031F |
3.3 Portugal Antivirals Market - Industry Life Cycle |
3.4 Portugal Antivirals Market - Porter's Five Forces |
3.5 Portugal Antivirals Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 Portugal Antivirals Market Revenues & Volume Share, By Actions, 2021 & 2031F |
4 Portugal Antivirals Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of viral diseases in Portugal |
4.2.2 Growing awareness about the importance of antiviral medications |
4.2.3 Technological advancements in antiviral drug development |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for drug approval in Portugal |
4.3.2 Competition from generic antiviral drugs |
4.3.3 High cost of antiviral medications |
5 Portugal Antivirals Market Trends |
6 Portugal Antivirals Market, By Types |
6.1 Portugal Antivirals Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Portugal Antivirals Market Revenues & Volume, By Type, 2021- 2031F |
6.1.3 Portugal Antivirals Market Revenues & Volume, By Hepatitis-C antivirals, 2021- 2031F |
6.1.4 Portugal Antivirals Market Revenues & Volume, By HIV antivirals, 2021- 2031F |
6.1.5 Portugal Antivirals Market Revenues & Volume, By Herpes antivirals, 2021- 2031F |
6.1.6 Portugal Antivirals Market Revenues & Volume, By Hepatitis-B antivirals, 2021- 2031F |
6.1.7 Portugal Antivirals Market Revenues & Volume, By Influenza antivirals, 2021- 2031F |
6.1.8 Portugal Antivirals Market Revenues & Volume, By Others, 2021- 2031F |
6.2 Portugal Antivirals Market, By Actions |
6.2.1 Overview and Analysis |
6.2.2 Portugal Antivirals Market Revenues & Volume, By DNA polymerase inhibitors, 2021- 2031F |
6.2.3 Portugal Antivirals Market Revenues & Volume, By NS3 Protease inhibitors, 2021- 2031F |
6.2.4 Portugal Antivirals Market Revenues & Volume, By Reverse transcriptase inhibitors, 2021- 2031F |
6.2.5 Portugal Antivirals Market Revenues & Volume, By Others, 2021- 2031F |
7 Portugal Antivirals Market Import-Export Trade Statistics |
7.1 Portugal Antivirals Market Export to Major Countries |
7.2 Portugal Antivirals Market Imports from Major Countries |
8 Portugal Antivirals Market Key Performance Indicators |
8.1 Number of new antiviral drug approvals in Portugal |
8.2 Patient adherence rate to antiviral drug treatments |
8.3 Investment in research and development for antiviral drugs |
9 Portugal Antivirals Market - Opportunity Assessment |
9.1 Portugal Antivirals Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 Portugal Antivirals Market Opportunity Assessment, By Actions, 2021 & 2031F |
10 Portugal Antivirals Market - Competitive Landscape |
10.1 Portugal Antivirals Market Revenue Share, By Companies, 2024 |
10.2 Portugal Antivirals Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |